IgA肾病肾小球免疫复合物沉积部位而非IgG共沉积影响肾脏结局
该多中心回顾性队列纳入80例IgA肾病活检,按是否IgG共沉积及沉积部位(仅系膜区 vs 系膜区+外周毛细血管壁)分组,中位随访29个月。结果显示IgG共沉积与复合肾脏结局无关,而免疫沉积累及外周毛细血管壁者基线蛋白尿更高、新月体/节段坏死更多,且更易达到复合终点。
要点
- IgG共沉积与IgA肾病复合肾脏结局无显著相关(P=0.82)。
- 免疫沉积累及外周毛细血管壁者复合终点风险显著升高(P=0.026)。
- 外周毛细血管壁沉积者基线蛋白尿更高(P=0.025),新月体/节段坏死更常见(P=0.047)。
核心结论
- 在IgA肾病中,IgG共沉积及肾小球免疫沉积部位均与活检组织学活动性相关,但仅外周毛细血管壁沉积与终末期肾病、移植、死亡和/或血肌酐翻倍的复合终点风险显著增加相关。
研究设计与样本
- 多中心回顾性队列研究,纳入80例IgA肾病活检,按IgG共沉积(IgA组n=55 vs IgA+IgG组n=25)及沉积部位(仅系膜区n=59 vs 系膜区+外周毛细血管壁n=21)分组,中位随访29个月。
主要发现
- IgG共沉积仅显示趋向内皮细胞增生(P=0.082),两组基线无其他差异;复合终点24例(IgA组16例 vs IgA+IgG组8例,P=0.82)。
- 外周毛细血管壁沉积组基线蛋白尿高于仅系膜区组(P=0.025),新月体/节段性肾小球坏死更常见(P=0.047),更易达到复合终点(P=0.026)。
- 伴新月体/节段性肾小球坏死的活检与内皮细胞增生相关(P<0.001)。
关键数值与推荐
- 复合主要终点为肾脏替代治疗、肾移植、死亡或血清肌酐(SCr)浓度翻倍。
- IgA组55例,IgA+IgG组25例;仅系膜区沉积59例,系膜区+外周毛细血管壁沉积21例。
- 中位随访29个月,共24例达到复合终点。
临床怎么用
- IgA肾病活检应关注免疫沉积是否累及外周毛细血管壁,该部位沉积提示更高组织学活动性及更差肾脏预后。
- IgG共沉积本身不独立预测复合肾脏结局,不宜单独作为预后判断依据。
局限性
- 回顾性设计、样本量较小(80例),随访时间较短(中位29个月),结论需更大队列验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It has been suggested that the prognosis of immunoglobulin (IgA) nephropathy (IgAN) is adversely affected if there is codeposition of IgG in the glomeruli or if immune deposits are present in the glomerular capillary walls. We sought to understand how these variables affect clinical outcome. METHODS: A total of 80 IgAN biopsies were retrospectively divided into groups: (i) IgA without IgG deposition versus IgA + IgG and (ii) immune deposits restricted to the mesangium versus mesangium and peripheral capillary walls (PCWs). The association of these groups with the composite primary outcome of renal replacement therapy, renal transplant, death or doubling of serum creatinine (SCr) concentration was determined. The change in estimated glomerular filtration rate (eGFR) was also assessed. Covariates examined were age, sex, race, SCr and proteinuria level at biopsy and at follow-up, duration of follow-up, treatment, Oxford score and presence of crescents. RESULTS: IgG codeposition showed a trend toward endocapillary hypercellularity (P = 0.082); there were no other baseline differences between the IgA (n = 55) and IgA + IgG (n = 25) groups. At a median follow-up time of 29 months, the combined primary outcome was reached in 24 patients, 16 with IgA and 8 with IgA + IgG (P = 0.82). Patients with immune deposits in the PCWs (n = 21) presented with higher baseline proteinuria than those with deposits limited to the mesangium (n = 59; P = 0.025), were more likely to have crescents/segmental glomerular necrosis on biopsy (P = 0.047) and were more likely to reach the combined primary outcome (P = 0.026). Biopsies with crescents/segmental glomerular necrosis were associated with endocapillary hypercellularity (P < 0.001). CONCLUSIONS: In this multicenter IgAN cohort, IgG co-deposition and the location of glomerular immune deposits in the PCWs were both associated with greater histologic activity on renal biopsy, but only the location of glomerular immune deposits in the PCWs was associated with a significantly increased risk for end-stage renal disease, transplant, death and/or doubling of SCr.
引用
- Alvarado AS, Andeen NK, Brodsky S, et al. Location of glomerular immune deposits, not codeposition of immunoglobulin G, influences definitive renal outcomes in immunoglobulin A nephropathy. Nephrol Dial Transplant. 2018. PMID: 28992348. doi:10.1093/ndt/gfx238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。